In 2006, the creation of sofie launched the aspiration of having a multifaceted approach to expand the reach of pet products for patients with advanced imaging needs This was further realized in 2017 with the addition of a radiopharmacy network with global distribution capabilities. Our team works alongside our pharma and academic partners to revolutionize clinical diagnostics and therapeutics to better understand and treat the biology of disease. Transparency in coverage (tic) regulations requires health insurers and group health plans to post their provider link on company websites View sofie’s link here view our privacy policy Our product lines include fdg, pylarify, neuraceq, and other clinical trial products.
We are currently performing data analysis and behind the scenes planning for phase 3 is well underway.
OPEN
